(Chris Woollams, CANCERactive) Fasting and calorie restriction can slow and even stop cancer progression and tumour growth, kill cancer cells and significantly improve chemo and radiotherapy effectiveness. Fasting has also been shown to boost the immune system, and reduce chemotherapy side-effects. A three or five day fast is something to seriously consider when having chemotherapy.
Leading cancer centres and experts such as Dr Valter Longo of University of Southern California, Professor Thomas Seyfried of Boston, Dr Dominic D´Agostino, Assistant Professor of Molecular Pharmacology, University of South Florida, and the Max-Plank Institute show that fasting can play an important therapeutic role in the treatment of cancer.
Fasting has been a part of the treatment of illness since Hippocrates and Plutarch was quoted as asserting, ‘Instead of using medicine, rather fast a day’. Between 2008 and 2013 there have been a number of research studies suggesting fasting can have significant beneficial effects with people trying to beat cancer, halting cancer progression, improving survival, reducing the side-effects of drugs and radiotherapy and even causing tumours to disappear. Here we look at the background and the research.
Calorie restriction and fasting
Calorie restriction (a reduction in energy intake without malnutrition - usually involving a reduction by 15% of calories consumed) is an interesting concept in the health field. It is linked to increased lifespan, better metabolism and reduced risk of chronic illness. (For example: Mattison JA, Lane MA, Roth GS, Ingram DK. Calorie restriction in rhesus monkeys. Exp Gerontol 2003;38:35–46).
In real life, during the second World War it was noted that populations such as the Belgians and Norwegians became healthier, with less cancer and heart disease, when they had calorie-restricted diets simply because of a lack of food.
Research studies with animals have shown longevity improvements of up to 40 per cent by reducing the intake of daily calories consumed to 10 to 15 per cent below ideal levels. There is some evidence that the effect is stimulated because calorie restriction causes the body to produce sirtuins, hormones that protect it in times of stress such as starvation might produce.
A 2007 report on research evidence by Krista A Vardy and Marc K Hellerstein showed that Alternate Day Fasting (where every other day, there is a fast consisting only of a 400 calorie meal for women and a 600 calorie meal for men) was associated with reduced blood levels of glucose, insulin, IGF-1 and ‘bad’ fats, with a long-term reduced risk of chronic diseases including diabetes, cardiovascular disease and cancer.
In early 2013, The Oncologist magazine commented in the Editorial on research that showed restricting calories in patients having radiotherapy produced better results. It suggests the same might be true of chemotherapy and calorie restriction, with clinical trials planned. So much for the NHS booklets telling you to pour dairy, sugar and sticky buns down your throat when having chemotherapy!
In 2014 Dr Valter Longo of University of Southern California showed that fasting caused ´old´ white immune cells to die. These were replaced from stem cells as soon as the subject recommenced eating. Thus a three day fast could regenerate a strong immune system - it also improved chemotherapy results and reduced side-effects.
Dr Dominic D´Agostino has done a considerable amount of work on Calorie Restriction, fasting and the Ketogenic Diet. Carbohydrate restriction will reduce levels of blood glucose, insulin and IGF-1, all implicated in the cancer development process. But when you have your next meal containing carbohydrates, the glucose and hormone levels will spike. This causes mood swings and the spikes can still aid cellular inflammation and cancer development.
To have an impact on cancer restriction, calorie restriction is essential. This induces ketosis in the body, a process where normal carbohydrate metabolism is replaced by ketone and fatty acid metabolism. Healthy cells have the flexibility to cope, but cancer cells are inflexible.
However, many people find the idea of ´fasting´ intolerable, so a step forward could well be the Ketogenic diet.
At CANCERactive we have already reviewed the Ketogenic Diet (Click Here), where all but non-starchy vegetable carbohydrates are banned and the patient follows a good fat and low but natural protein-focused diet. The core thinking is to deprive the cancer of its favourite food, glucose.
In Cancer Watch we have covered several research studies that show people with the highest blood plasma glucose levels get more cancers; and people with cancer who have the highest plasma glucose levels, survive least. Indeed there is increasing evidence that even more worrisome may be high fructose corn syrup in fizzy soft drinks.
While cancer cells have to have glucose to metabolise, healthy cells can use other foods such as fat. The process is termed ketosis. Starve the body of glucose by providing calories in the form of good fats and you may well be able to starve, and therefore kill off, the cancer.
There is also some evidence that some cancer cells may be able to switch to glutamine, an amino acid from protein. And also that high protein drives the mTOR pathway which causes cancer cell proliferation. So restricted protein consumption seems important too.
The question is therefore: Since ketosis will occur under starvation conditions anyway, do you need to employ the Ketogenic diet, or can you merely go on a fast?
Several mechanisms are possibly beneficial in fasting
Many factors are at work during fasting, including less aggressive hormone production, less circulating ‘bad’ cholesterol, glucose deprivation and sirtuin stimulation. Sirtuins are highly protective hormones known to be produced under conditions of food deprivation. Food deprivation is also (not surprisingly) associated with leaner bodies.
A thinner body would have lowered fat stores and fat is the precursor of oestrogen, a hormone known to stimulate many cancers. Fat is also a wonderful solvent and so a body with less fat stores contains less dissolved toxins. This is less important around your waist that it is around your organs. This fat you cannot see is called visceral fat and it is now thought capable of bathing your internal organs in a slew of toxins, which dieting might avoid. Certainly research on exercise has shown that visceral fat starts to liquefy after only 15 minutes of exercise.
A few years ago, we covered research from Northwestern Medical School in the context of breast cancer patients. This showed overweight women survived less that women of optimum weight. Interestingly it concluded that it was never too late to start, and that women who cut their weight to correct levels did survive longer.
All this fits with the American Cancer Society’s 2012 Research Report that stated there had been an explosion of research into complementary therapies since 2006 and that there was overwhelming evidence that diet, exercise and weight control could improve survival times and even prevent a cancer returning.
Fasting as a cancer treatment
It was interesting to read the story of a lady who wrote into CANCERactive after we ran a story on Calorie Restriction in our e magazine, telling us how her Doctor father who specialized in cancer achieved remarkable results by putting his patients on a water-only fast before treating them.
The next correspondence came a Doctor from India who puts everybody he receives on a fasting regime at the outset after diagnosis and does not start treatment for a couple of months. He claims that results are impressive and that fasting starves the cancer more than the patient.
Of course, many cancer experts will point to the severe weight loss involved in cachexia and its dangers. But this is a very different issue – it is an uncontrolled weight loss caused by the side-effects of the chemotherapy drugs and side-effects such as nausea reducing the desire to eat. This is not controlled weight loss but a drug-induced illness.
Research with lung cancer patients on chemotherapy showed that omega-3 from fish oils could help people regain their appetite and weight, avoiding cachexia. It may be true for other cancers. But then eating bad fats has been linked to poorer survival rates in women with breast cancer, whereas eating good fats (like omega-3 and extra virgin olive oil) has been linked to increased survival times. And so we come full circle to Calorie Restriction and the Ketogenic diet as two options.
Interestingly, in Cancer Watch we also covered recommendation on diet from MD Anderson and Sloan-Kettering which are in stark contrast to the recommendations of the UK NHS for patients on chemo. While the UK NHS has an ‘eat lots of calories, lots of sugary buns, milky sugary tea, even cheeseburgers and milk shakes’ approach, the two top American Hospitals tell people to eat nutritiously and carefully, to provide plenty of nourishment and vitamins and minerals. To top it all, the National Cancer Institute have published their own research showing a bad diet can help cancer stem cells at the core of tumours to re-grow, while a healthy diet can prevent this – the bioactive natural compounds included were curcumin, EGCG from green tea, piperine, theanine and choline, vitamins A and E (the all natural 8 variety version), genistein, and resveratrol and sulphoraphanes, all of which, they said, you could find in supplements.
So, should fasting be part of your integrative cancer programme? And is that a total, water-only fast? Should you maintain some intake of anti-cancer natural compounds?
1 Fasting and chemotherapy
The National Cancer Institute of America is interested in fasting because they recognize that the foods you eat can affect the way your body absorbs and reacts to drugs.
For them, fasting may well be a way of helping chemotherapy deliver better results, with less side-effects and more cost-effectively.
They quote the work of Dr. Valter Longo, a professor of gerontology and biological science at the University of Southern California (USC) who in various studies since 2008 has shown that fasting for two to three protected healthy cells in both cultures and living mice with cancer tumours from chemotherapy drugs without protecting cancer cells. They called this ‘differential stress resistance’.
The researchers then published a study of 10 elderly cancer patients who voluntarily underwent short-term fasting before and/or after chemotherapy. The patients reported far fewer side-effects. In 2012 in response to arguments that fasting might promote cancer growth, the same team produced further research (Science Translational Medicine; 7 March 2012) showing that fasting makes cancer cells more sensitive to chemotherapy. Fasting actually stopped cancer cells producing protection proteins from their mutated genes, while healthy cells made more protective proteins. As a result the healthy cells stop dividing and are less attacked by the chemotherapy resulting in lowered side-effects. In some combinations of fasting and chemotherapy the tumours actually disappeared. So fasting can improve effectiveness. And reduce the side-effects of chemotherapy.
But the team identified a second factor working against the cancer cells: Fasting deprives a cancer cell of glucose. Dr Longo describes these as two stressors acting simultaneously.
Indeed, in animal studies (mice with implanted breast cancer, melanoma or glioma cells) short-term fasting alone delayed tumor growth to the same extent as treatment with the drug cyclophosphamide!
In mice with cancer, fasting plus chemo significantly increased survival times and metastases. The UCS team showed that mice with brain tumours who fasted had a 20 to 40 per cent longer remission period.
Three clinical trials are now planned helped by Dr Longo and his work. Furthermore, a group of 12 cancer centres across the world is planning two clinical trials – one at whether fasting can reduce chemo side-effects; the other at whether fasting can improve chemotherapy effectiveness.
According to USC research, 70 per cent of cancer patients would refuse a water-only fasting regime if offered. So, to mask this problem, a product called Chemolieve has been developed which provides no nutrients to cancer cells!
However, pharmaceutical companies might not be so happy if fasting (or what is now being called ‘The Food Effect’) means less drugs are needed. Elsewhere on this website we have already covered how some foods negatively react with some drugs. But some foods aid the action of other drugs. And now some pharmaceutical companies are even suggesting that fasting would allow the use of greater volumes of their drugs!
2 Insulin, IGF-1 and more
Some cancer ‘experts’ are warning that people with diabetes are at risk if they were to fast. There is no doubt you should check this with your doctor. But there is strong evidence that a three to five day diet actually helps the 70 per cent of Western populations who have ‘insulin resistance’. Research is clear that insulin levels decrease in a fasting body. Michelle Harvie at the University of Manchester, UK has studied women whose family history puts them at high risk of developing breast cancer. Half of her subjects went on a 25 per cent calorie restriction diet while the others did a two day a week fast. After six months, both groups showed a reduction in blood insulin levels, but this was greater in the fasting group. Studies are now underway looking at levels of breast cell mutation.
Research showed levels of IGF-1 (Insulin-like Growth Hormone) also fall significantly, and quickly. Both insulin and IGF-1 are linked with higher rates of cancer.
Alternate day fasting has been linked with lowered ‘bad’ cholesterol and blood pressure, according to researcher Krista Varady of the University of Illinois-Chicago.
Longo’s team at USC found that a 48 hour fast slowed the growth of five of the eight cancers they were studying.
3 Preventing dormant cancers becoming active
In a March 2013 paper by the Max-Planck Institute in Germany, they argue that tumour cells often lie dormant in the body with as many dying off as replicating. When an event to change this occurs it usually sees messenger compounds being produced which stimulate blood supply development and therefore tumour growth. The Institute argue that the obvious step is to stop nutrients feeding this change, leaving the dormant cells in a harmless state. Their work, entitled ‘Fasting time for cancer cells’ looks at lung cancer.
4 Using fasts to beat cancer
We have probably saved the best until last: Boston College biology Professor Dr. Thomas N. Seyfried is a firm advocate of using fasting in the treatment of cancer.
In his book, ’Cancer as a metabolic disease’ and in an article (http://www.nutritionandmetabolism.com/content/7/1/7) with Laura M Shelton, which involved contributions from expert scientists (including those of Harvard Medical School and Memorial Sloan-Kettering) Seyfried explains a number of phenomenon:
1. Impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin.
2. Genomic instability and essentially all the hallmarks of cancer, including aerobic glycolysis (the Warburg effect), can be linked to impaired mitochondrial function and energy metabolism.
3. A view of cancer as primarily a metabolic disease will increasingly impact approaches to cancer management and prevention.
4. Although no specific gene mutation or chromosomal abnormality is common to all cancers, nearly all cancers express aerobic glycolysis, regardless of their tissue or cellular origin. Aerobic glycolysis in cancer cells involves elevated glucose uptake with lactic acid production in the presence of oxygen. This fact is used in tumour imaging studies. Genes for glycolysis are overexpressed in the majority of cancers examined.
5. Cancer cells would therefore arise from normal body cells through a gradual and irreversible damage to their respiratory capacity. Aerobic glycolysis, arising from damaged respiration, is the single most common phenotype found in cancer.
6. Warburg´s idea on the primary cause of cancer, i.e., the replacement of respiration by fermentation (glycolysis), was only a symptom of cancer and not the cause. Emerging evidence questions the genetic origin of cancer and suggests that cancer is primarily a metabolic disease.
7. Besides glucose, glutamine can also serve as a major energy metabolite for some cancers (for example, with brain tumours)
8. If cancer is primarily a disease of energy metabolism, then rational approaches to cancer management can be found in therapies that specifically target energy metabolism.
9. Reduced glucose availability will target aerobic glycolysis and the pentose phosphate shunt; pathways required for the survival and proliferation of many types of tumor cells. Dietary energy restriction specifically targets the IGF-1/PI3K/Akt/HIF-1α signaling pathway, which underlies several cancer hallmarks to include cell proliferation, evasion of apoptosis, and angiogenesis
10. Besides lowering circulating glucose levels, dietary energy restriction elevates circulating levels of fatty acids and ketone bodies (β-hydroxybutyrate and acetoacetate). Fats and especially ketone bodies can replace glucose as a primary metabolic fuel under calorie restriction.
11. The shift from the metabolism of glucose to the metabolism of ketone bodies for energy is due largely to the shift in circulating levels of insulin and glucagon, key hormones that mediate energy metabolism. Insulin, which stimulates glycolysis, is reduced under dietary restriction, while glucagon, which inhibits glycolysis and mobilizes fats, is increased. Glucose reduction not only reduces insulin, but also reduces circulating levels of IGF-1, which is necessary for driving tumour cell metabolism and growth. Glucocorticoids, which enhance glucagon action and the stress response, are also elevated under dietary energy restriction. The shift in levels of these metabolic hormones would place greater physiological stress on the tumor cells than on normal cells since the tumor cells lack metabolic flexibility due to accumulated genetic mutations.
12. Proof of concept for cancer metabolic therapy was illustrated for the management of malignant astrocytoma in mice, and malignant glioma in children. Prostate and gastric cancer also appears manageable using low carbohydrate ketogenic diets. Recent studies show that dietary energy restriction enhances phosphorylation of adenosine monophosphate kinase (AMPK), which induces apoptosis in glycolytic-dependent astrocytoma cells, but protects normal brain cells from death.. This further illustrates the differential response of normal cells and tumor cells to energy stress.
All references can be found by referring to the article.
His final views may overcome the ‘What about cachexia?’ critics. I quote, ‘It is important to recognize that pro-cachexia molecules such as proteolysis-inducing factor are released from the tumor cells into the circulation and contribute to the cachexia phenotype. By targeting the glycolytically active tumor cells that produce pro-cachexia molecules, restricted diet therapies can potentially reduce tumor cachexia. These therapies could be supplemented with omega-3 fatty acids, which can also reduce the cachexia phenotype. Omega-3 fatty acids from fish oil also have the benefit of maintaining low glucose while elevating ketone levels. Once the tumor becomes managed, individuals can increase caloric consumption to achieve weight gain’.
In 2012 Cancer Watch covered research studies showing that fish oils did indeed reduce cachexia levels in lung cancer patients.
At CANCERactive we have always been of the view that there is ALREADY sufficient knowledge in the world to beat cancer. We do not believe the future is about raising monies to develop new synthetic compounds that may ‘cure’. Most of, if not all, the science is already there. We have long brought you the research and the science covering a number of factors which, when added together, may well already be enough to increase survival times and even prevent a cancer returning. We believe the real issue is bringing existing research to the attention of all people trying to beat cancer.
It is quite clear that there are a number of, sometimes dangerous, myths that abound in modern medicine. One such myth starts with the fear that drugs might produce death from cachexia and results in hospitals recommending diets that might feed the very cancer the patient and the oncologist are trying to beat.
It is becoming increasingly clear that cancers need specific nutrients to encourage their growth, and without these nutrients the cancer withers. Maybe not all cancers, but many. Glucose is clearly one such nutrient, although there undoubtedly are others.
Fasting reduces plasma glucose, IGF-1 and insulin levels and produces a state of ketosis which clearly has health benefits, one of those being to deprive cancer cells of nutrients. Cutting protein consumption has further anti-inflammatory and cancer-driving mechanisms. That fasting may help chemotherapy or radiotherapy success is a different, and probably confusing point.
Whether fasting can ‘cure’ a cancer on its own is clearly debatable and controversial. Whether one should add in the concept of a ketogenic diet to make the fasting ketosis more effective - and more tolerable is interesting. It seems quite possible to further starve the cancer cell whilst using natural compounds like fish oils, resveratrol (which stimulates the production of sirtuins), ECGC (green tea), curcumin, vitamin D and others to add anti-cancer effects, but this is still to be proven.
But readers should ask themselves, ‘On balance, do I think the use of fasting and/or a Ketogenic diet could be a useful part of my anti-cancer programme?’ The evidence increasingly seems to come out in favour.
Interestingly, when this article first appeared, I received several letters of praise from oncologists in America, where it seems to be quite a ´hot topic´. Thank you.
You might also like to read: The KETOGENIC DIET.
CANCERactive - leading the way in Integrative Oncology.
It's the future.